Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virological and immunological assessment in HIV positive participants on 2DR versus 3DR
2024-515265-34-00Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in human immunodeficiency virus infection (HIV) comparing Two-drug regimen (Dovato) with Three-drug regimen (Biktarvy) (2 arms). Started Oct 2024; status: completed.
02
Drugs
bictegravir + emtricitabine + tenofovir alafenamidedolutegravir + lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2024-515265-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515265-34-00.